AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24617431 — intervention group
Group type: COMPARATOR
Intervention: Ciclosporin (2.5 mg kg(‐1) daily)
Number of subjects: 40
Study 22068879 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention training followed by memory training
Number of subjects: 51
Study 22068879 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory training followed by attention training
Number of subjects: 51
Study 22068879 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive training)
Number of subjects: 51
Study 20048271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural competency training and monthly race-stratified performance reports
Number of subjects: 2699
Study 17630653 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 202
Study 17630653 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 202
Study 15701591 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate ointment (Daivobet/Dovobet), applied once daily for 4 weeks.
Number of subjects: 1534
Study 11840365 — intervention group
Group type: COMPARATOR
Intervention: Usual hematocrit (30%-33%) with no exercise training (UH)
Number of subjects: 65
Study 11840365 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual hematocrit (30%-33%) plus exercise training (UHX)
Number of subjects: 65
Study 11840365 — intervention group
Group type: COMPARATOR
Intervention: Normalized hematocrit (40%-42%) with no exercise training (NH)
Number of subjects: 65
Study 11840365 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized hematocrit (40%-42%) plus exercise training (NHX)
Number of subjects: 65
Study 10520159 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete dental restoration
Number of subjects: 54
Study 10520159 — intervention group
Group type: EXPERIMENTAL
Intervention: Local application of amphotericin B
Number of subjects: 54
Study 10520159 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dental treatment plus amphotericin B
Number of subjects: 54
Study 10520159 — intervention group
Group type: COMPARATOR
Intervention: Caries-free subjects (Control)
Number of subjects: 54
Study 7781398 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus concurrent radiation therapy
Number of subjects: 0
Study 7781398 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 0
Study 2478278 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound and slide presentation
Number of subjects: 666
Study 2478278 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal demonstration
Number of subjects: 666
Study 2478278 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 666
Study 1080560 — intervention group
Group type: EXPERIMENTAL
Intervention: Gently oscillating waterbed
Number of subjects: 21
Study 1080560 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-oscillating waterbed
Number of subjects: 21
Study 1080560 — intervention group
Group type: COMPARATOR
Intervention: Control group (no waterbed)
Number of subjects: 21
Study 31650315 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating single file, single cone technique
Number of subjects: 120
Study 31650315 — intervention group
Group type: COMPARATOR
Intervention: Hand files and lateral compaction technique
Number of subjects: 120
Study 31234840 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention including identification of drug related problems, drug interactions, change in dose, frequency and therapy switches, and non-pharmacological intervention consisting of diet, lifestyle and behavior counseling
Number of subjects: 244
Study 31234840 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 244
Study 31234840 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 244
Study 29217757 — intervention group
Group type: EXPERIMENTAL
Intervention: Elamipretide (0.25 mg·kg‐1·h‐1)
Number of subjects: 32
Study 29217757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 25195661 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoActivator (group EA)
Number of subjects: 72
Study 25195661 — intervention group
Group type: COMPARATOR
Intervention: Endodontic irrigating needle (group EN)
Number of subjects: 72
Study 23803594 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 48
Study 23803594 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 10 µg kg(‐1)
Number of subjects: 48
Study 23803594 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 20 µg kg(‐1)
Number of subjects: 48
Study 23803594 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 30 µg kg(‐1)
Number of subjects: 48
Study 21814293 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict blood pressure control (target systolic BP <140 mm Hg)
Number of subjects: 2865
Study 21814293 — intervention group
Group type: COMPARATOR
Intervention: Mild blood pressure control (target systolic BP 140-159 mm Hg)
Number of subjects: 2865
Study 19339405 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in liquid calorie intake of 100 kcal/d
Number of subjects: 810
Study 19339405 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in sugar-sweetened beverage (SSB) intake of 1 serving/d
Number of subjects: 810
Study 21795297 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel withdrawal
Number of subjects: 33
Study 16330915 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel in combination with aspirin
Number of subjects: 0
Study 16330915 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0
Study 16330915 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antiplatelet therapy with clopidogrel and aspirin
Number of subjects: 0
Study 16330915 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibition
Number of subjects: 0
Study 12186987 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified FSH (Fostimon)
Number of subjects: 153
Study 12186987 — intervention group
Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (Menogon)
Number of subjects: 153
Study 9615851 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 18
Study 9615851 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 18
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with non-insulin-dependent diabetes mellitus
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with impaired glucose tolerance
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Area under the non-esterified fatty acid suppression curve
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-hip ratio
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting insulin concentration
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min insulin increment
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1122
Study 7806018 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 1122
Study 2642707 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 45
Study 2642707 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 45
Study 51576 — intervention group
Group type: EXPERIMENTAL
Intervention: Menaquinone therapy alone
Number of subjects: 191
Study 51576 — intervention group
Group type: EXPERIMENTAL
Intervention: Menaquinone therapy with hyposensitization therapy
Number of subjects: 191
Study 51576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 11595381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone challenge in healthy subjects
Number of subjects: 0
Study 11595381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone challenge in mild asthmatic subjects
Number of subjects: 0
Study 31337037 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-grafts from Human Intra- and Extra-Dermal Adipose Tissue-Derived Hair Follicle Stem Cells (HD-AFSCs)
Number of subjects: 33
Study 31337037 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 33
Study 31337037 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-grafts from HD-AFSCs
Number of subjects: 33
Study 30111240 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenease therapy (mechanical high-frequency vibration device)
Number of subjects: 54
Study 30111240 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (physiotherapy, activity modification, and analgesia)
Number of subjects: 54
Study 28065227 — intervention group
Group type: EXPERIMENTAL
Intervention: Brochure group
Number of subjects: 134
Study 28065227 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 134
Study 25388660 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (Mobile Technology for Improved Family Planning)
Number of subjects: 0
Study 22119614 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour-coded HbA1c graphical record
Number of subjects: 0
Study 22119614 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 19861956 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (HT) for 12 weeks
Number of subjects: 46
Study 19861956 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) for 12 weeks
Number of subjects: 46
Study 17593012 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical pranoprofen 0.1%
Number of subjects: 40
Study 17593012 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium 0.1%
Number of subjects: 40
Study 16333028 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC14 (604 patients)
Number of subjects: 1214
Study 11972097 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic red cell transfusion (exchange or simple transfusion with washed, reconstituted, or packed red blood cells)
Number of subjects: 61
Study 11972097 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple transfusion with packed red cells
Number of subjects: 61
Study 11972097 — intervention group
Group type: EXPERIMENTAL
Intervention: Exchange transfusions
Number of subjects: 61
Study 11972097 — intervention group
Group type: EXPERIMENTAL
Intervention: Total transfusion volume of more than 250 mL/kg
Number of subjects: 61
Study 9504437 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 0100 h
Number of subjects: 12
Study 9504437 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 0700 h
Number of subjects: 12
Study 9504437 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 1300 h
Number of subjects: 12
Study 9504437 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline orally at 1900 h
Number of subjects: 12
Study 8699518 — intervention group
Group type: EXPERIMENTAL
Intervention: Threaded, hydroxylapatite-coated implant
Number of subjects: 720
Study 2759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum isometric exercise
Number of subjects: 40
Study 2759322 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40
Study 2759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 40
Study 132695 — intervention group
Group type: EXPERIMENTAL
Intervention: Feprazone, 200 mg t.d.s.
Number of subjects: 23
Study 132695 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin, 25 mg t.d.s. rising to 50 mg t.d.s.
Number of subjects: 23
Study 30939411 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counseling intervention (11 sessions over 6 months)
Number of subjects: 115
Study 30939411 — intervention group
Group type: COMPARATOR
Intervention: Control group (no behavioral counseling)
Number of subjects: 115
Study 30939411 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counseling intervention
Number of subjects: 115
Study 30939411 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study 29187388 — intervention group
Group type: COMPARATOR
Intervention: Almond diet (ALD) - 42.5 g/d of almonds
Number of subjects: 48
Study 29187388 — intervention group
Group type: COMPARATOR
Intervention: Chocolate diet (CHOC) - 18 g/d of cocoa powder and 43 g/d of dark chocolate
Number of subjects: 48
Study 29187388 — intervention group
Group type: COMPARATOR
Intervention: Combined diet (CHOC+ALD) - all 3 foods (almonds, dark chocolate, cocoa)
Number of subjects: 48
Study 29187388 — intervention group
Group type: EXPERIMENTAL
Intervention: Average American diet (control)
Number of subjects: 48
Study 25194428 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile tea (3 g/150 mL hot water) three times per day immediately after meals for 8 weeks
Number of subjects: 64
Study 25194428 — intervention group
Group type: COMPARATOR
Intervention: Water regimen for 8 weeks
Number of subjects: 64
Study 22402823 — intervention group
Group type: EXPERIMENTAL
Intervention: Educoeur
Number of subjects: 185
Study 22402823 — intervention group
Group type: COMPARATOR
Intervention: Specialized clinic
Number of subjects: 185
Study 22402823 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 185
Study 21984399 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin (AST) 4 mg/d for 28 days
Number of subjects: 21
Study 21984399 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study 19390720 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheostomy with isthmectomy (11 by general surgery team, 11 by thoracic surgery team)
Number of subjects: 164
Study 19390720 — intervention group
Group type: COMPARATOR
Intervention: Tracheostomy without isthmectomy
Number of subjects: 164
Study 16505653 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic tube compensation (ATC) with continuous positive airway pressure (CPAP) during a spontaneous breathing trial (n=51)
Number of subjects: 99
Study 16505653 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) alone during a spontaneous breathing trial (n=48)
Number of subjects: 99
Study 16505653 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic tube compensation (ATC) with CPAP
Number of subjects: 99
Study 16505653 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) alone
Number of subjects: 99
Study 12754584 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition (Group II)
Number of subjects: 28
Study 12754584 — intervention group
Group type: COMPARATOR
Intervention: Bolus enteral nutrition (Group I)
Number of subjects: 28
Study 12754584 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group I and Group II)
Number of subjects: 28
Study 11119744 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS women
Number of subjects: 27
Study 11119744 — intervention group
Group type: COMPARATOR
Intervention: Healthy control women
Number of subjects: 27
Study 8796411 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac surgery with cardiopulmonary bypass
Number of subjects: 13
Study 1636574 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (1.5 million units/60 minutes)
Number of subjects: 333
Study 1636574 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anistreplase (30 units/2 to 5 minutes)
Number of subjects: 333
Study 1636574 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase or anistreplase
Number of subjects: 333
Study 6434084 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 200
Study 6434084 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 200
Study 31914443 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen immunotherapy (AIT) plus pharmacological treatment
Number of subjects: 250
Study 31914443 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 250
Study 30507881 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint application (plasters applied to designated points such as Tianzhu, Lianquan, Dazhui) before operation
Number of subjects: 880
Study 30507881 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 880
Study 29369985 — intervention group
Group type: EXPERIMENTAL
Intervention: External levator advancement
Number of subjects: 40
Study 29369985 — intervention group
Group type: COMPARATOR
Intervention: Müller muscle-conjunctival resection
Number of subjects: 40
Study 26605807 — intervention group
Group type: COMPARATOR
Intervention: 1-minute rest intervals (SHORT)
Number of subjects: 21
Study 26605807 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute rest intervals (LONG)
Number of subjects: 21
Study 26605807 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 21
Study 24595228 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial sevoflurane delivery
Number of subjects: 26
Study 24595228 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic sevoflurane delivery
Number of subjects: 26
Study 24595228 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sevoflurane)
Number of subjects: 26
Study 24595228 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane treatment (both intramyocardial and systemic)
Number of subjects: 26
Study 23318240 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilization and household level waste management intervention
Number of subjects: 1600
Study 23318240 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1600
Study 19939196 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral folic acid supplement
Number of subjects: 26
Study 19939196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no folic acid)
Number of subjects: 26
Study 17345047 — intervention group
Group type: EXPERIMENTAL
Intervention: Median Nerve Stimulation (MNS)
Number of subjects: 11
Study 17345047 — intervention group
Group type: COMPARATOR
Intervention: Control Stimulation (CS)
Number of subjects: 11
Study 16262545 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion with brief motivational counseling
Number of subjects: 600
Study 16262545 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 600
Study 12141578 — intervention group
Group type: EXPERIMENTAL
Intervention: COOP Charts with illustrations
Number of subjects: 6007
Study 12141578 — intervention group
Group type: COMPARATOR
Intervention: COOP Charts without illustrations
Number of subjects: 6007
Study 10683816 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (1.5 g DHA per day for 9 weeks)
Number of subjects: 14
Study 10683816 — intervention group
Group type: COMPARATOR
Intervention: Control (10 capsules of mixed plant oil per day for 9 weeks)
Number of subjects: 14
Study 8944094 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 40
Study 8944094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1836824 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (n = 15): respiration adjusted to maintain constant end-tidal CO2
Number of subjects: 30
Study 1836824 — intervention group
Group type: COMPARATOR
Intervention: Group II (n = 15): minute ventilation kept constant to monitor end-tidal CO2 changes
Number of subjects: 30
Study 6130079 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (10 mg t.i.d.)
Number of subjects: 131
Study 6130079 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg t.i.d.)
Number of subjects: 131
Study 6130079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 30511951 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training plus home exercise
Number of subjects: 40
Study 30511951 — intervention group
Group type: COMPARATOR
Intervention: Home exercise only
Number of subjects: 40
Study 28319001 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers (WW) approach supplemented with phone and email counseling with a certified diabetes educator (CDE)
Number of subjects: 563
Study 28319001 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC) - brief standard diabetes nutrition counseling and education
Number of subjects: 563
Study 26120988 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasonit and standard treatment
Number of subjects: 45
Study 26120988 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 45
Study 22773619 — intervention group
Group type: EXPERIMENTAL
Intervention: Comics for Health program
Number of subjects: 0
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (baseline)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse pressure (baseline)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (baseline)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist circumference (baseline)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen (baseline)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (cumulative exposure)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Current levels of augmentation index
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse pressure heart rate product (20 years)
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Established cardiovascular risk factors
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation and repetitive cyclic stress
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute inflammation
Number of subjects: 825
Study 20530296 — intervention group
Group type: EXPERIMENTAL
Intervention: Control of pulse pressure and heart rate, reducing inflammation
Number of subjects: 825